RenovoRx Inc expected to post a loss of 8 cents a share - Earnings Preview

RenovoRx

12/08/2025 22:00

RenovoRx Inc RNXT.OQ RNXT.O is expected to  show a rise in quarterly revenue when it reports  results on August 14 for the period ending June 30 2025

The Mountain View California-based  company is expected to report revenue of $329.67 thousand, according to the mean estimate from 3 analysts, based on LSEG data.

‚ÄčLSEG's mean analyst estimate for RenovoRx Inc is for a loss of 8 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ‚Äč

Wall Street's median 12-month price target for RenovoRx Inc is $3.75, about 70.3% above its last closing price of $1.12

Previous quarterly performance (using preferred earnings measure in US dollars). ‚Äč

QUARTER ENDING
STARMINESMARTESTIMATE¬ģ
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-0.08
-0.08
-0.08
Met
0
Dec. 31 2025
-0.12
-0.11
-0.13
Missed
-18.2
Sep. 30 2024
-0.12
-0.12
-0.10
Beat
16.7‚Äč
Jun. 30 2024
-0.10
-0.10
-0.10
Met
0
‚Äč‚ÄčMar. 31 2024
-0.13
-0.14
-0.07
Beat
51.7
Dec. 31 2023
-0.30
-0.30
-0.31
Missed
-2.2‚Äč
Sep. 30 2023
-0.30
-0.30
-0.13
Beat
56.7
Jun. 30 2023
-0.25
-0.25
-0.31
Missed
-24

This summary was machine generated August 12 at 21:00 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)